UL36ANTI

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameUL36ANTI
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProtein synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAceragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAceragen Inc
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A